cytokine inhibiting gels (Washburn)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namecytokine inhibiting gels (Washburn)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCytokine receptors antagonists
TargetsCytokine receptorsInterleukin 18 receptor
Therapy Area/IndicationsWounds and InjuriesInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWashburn Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWashburn Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesInflammation

Other Information

ATC CodeN/A
Related LinksN/A